ACD Working Group on Artificial Intelligence

Background

The goal of this working group is to articulate a strategic and integrated vision for biomedical research opportunities that would benefit from developing novel AI methods that could both: (a) ensure increase in data collection from the clinical care environment, including all populations, and (b) augment the tools and capabilities for biomedical research to facilitate optimal and especially ethical use of AI for health.

Charge

The ACD AI WG is charged with articulating a strategic and integrated vision for biomedical research opportunities that would benefit from developing and application of novel AI methods. In considering this charge, the AI WG's recommendations should address the following:

  • Assess progress to date and develop a framework to support strategic priorities and biomedical research opportunities in AI, particularly involving the development and application of novel methodologies (i.e. foundational models, multimodal generative AI, Edge AI, etc) for knowledge discovery and human health. This should include the necessary data and computing resources that will be required for using and scaling AI in biomedicine, allowing for interdisciplinary collaboration across fields.
  • With respect to these priorities, define the potential privacy, security, ethical, policy, and cost challenges that NIH should consider in supporting and deploying AI to maximally benefit the biomedical enterprise. Consider potential approaches for mitigating these challenges, including new areas of science that could be developed.
  • Recommend strategies for ensuring equitable benefits result from these strategic priorities, including equitable benefits in inclusive algorithmic development, the application of transparent and explainable AI, and collaborative training programs to enable a health learning environment using AI and AI-enabled tools.

Working Group Reports

  • Coming Soon.

Related Resources

  • Coming Soon.

Roster

  • Katerina Antypas, M.S. — Director, Office of Advanced Cyberinfrastructure, National Science Foundation (NSF)
  • Caroline Chung, M.D. — Vice President and Chief Data Officer and Director of Data Science Development and Implementation of the Institute for Data Science in Oncology, MD Anderson Cancer Center, Houston, TX
  • Matthew Diamond, M.D., Ph.D. — Chief Medical Officer, Digital Health Center of Excellence, U.S. Food and Drug Administration (FDA)
  • Tina Hernandez-Boussard, Ph.D. — Associate Dean of Research; Professor of Medicine, Stanford University, Stanford, CA
  • Eric Horvitz, M.D., Ph.D. — Chief Scientific Officer, Microsoft, Redmond, WA
  • Aaron Lee, M.D., C. Dan and Irene Hunter — Endowed Professor, University of Washington, Seattle, WA
  • Jiang Bian, Ph.D., Professor — Chief Data Scientist; Chief Research Information Officer, University of Florida Health, Gainsville, FL
  • Omolola Ogunyemi, Ph.D., Professor — Director of the Center for Biomedical Informatics, Charles R. Drew University of Medicine and Science, Los Angeles, CA

CO-CHAIRS

  • Susan Gregurick, Ph.D. — Associate Director for Data Science; Designated Federal Official, National Institutes of Health (NIH)
  • Lucila Ohno-Machado, M.D., M.B.A., Ph.D. — Deputy Dean for Biomedical Informatics, Yale University, New Haven, CT

EXECUTIVE SECRETARY

  • Mohd Anwar, Ph.D. — Lead of Foundational AI, Office of Data Science Strategy (ODSS), NIH

This page last reviewed on December 05, 2024